Clinical Trial Update: Safety and Immunogenicity of a Group B Streptococcus Vaccine in Non-pregnant Women 18-40 Years of Age. [Phase 1]

View source ↗

Summary

Phase 1 trial assessing safety and immunogenicity of a Group B Streptococcus vaccine in non-pregnant women aged 18-40 years.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infection By Streptococcus Group

Drugs mentioned

• Group B Streptococcus vaccine

Snippet

Sponsor: Minervax ApS | Conditions: Infection by Streptococcus Group B | Phase 1 | Status: COMPLETED | Results posted: 2021-01-14